Over the many stocks that managed to record considerable gains over the course of the past month or so, the performance from the Sunshine Biopharma, Inc. (OTC: SBFM) stock has been quite remarkable.
During that period, the stock has rallied by as much as 600% to emerging as one of the biggest gainers in its sector, and on Tuesday, the rally continued. Yesterday, the stock surged by as much as 26%. Although there was no news with regards to the company, the rally might be linked to the uplisting application from Sunshine last week.
Back on January 27, the company announced that it had completed its application for uplisting the stock to OTCQB from the OTC Markets Pink. It is a significant development for the company as well as its investors. The uplisting is going to give Sunshine access to a larger pool of investors and more importantly, it will allow institutional investors to invest in the company.